Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A.P. (Geke) Hospers

Publicaties

Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry

Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study

Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients

A prediction model for response to immune checkpoint inhibition in advanced melanoma

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

Baseline tumor-infiltrating lymphocyte patterns and response to immune checkpoint inhibition in metastatic cutaneous melanoma

BRAF/MEK inhibitor rechallenge in advanced melanoma patients

Comment on the RAPIDO Trial Point-Counterpoint Debate

Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer

Corticosteroids and other immunosuppressants for immune-related adverse events and checkpoint inhibitor effectiveness in melanoma

Lees meer

Pers/media

‘Het mooie is dat je het microbioom kunt veranderen’

Darmflora beïnvloedt effectiviteit immunotherapie bij huidkanker

Effectiviteit darmflora beïnvloed immunotherapie bij huidkanker

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients

Lees meer